Lebrikizumab

A roundup of the most newsworthy healthcare press releases from PR Newswire this week, including the latest FDA approvals, health policy news and highlights from ESMO Congress 2024. NEW YORK, Sept. 20, 2024 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help healthcare journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that are available for download. Continue Reading PR Newswire Weekly Health Press Release Roundup, Sept. 16-20, 2024. Photo provided by Aflac. Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk "For so long, we've been conditioned to fear aging, but the reality is that age is power," Shields said. She directs a short film encouraging adults 50 years of age and older to talk to their doctor or pharmacist about their risk for shingles — and about vaccination. FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis "Eczema can affect people of all skin tones, ethnicities, genders and ages. Nearly 16.5 million adults in the U.S. have eczema, with 6.6 million experiencing moderate-to-severe…," said Kristin Belleson, President and CEO of the National Eczema Association. "The approval of EBGLYSS provides hope and promise for the eczema community and those still seeking lasting relief from disruptive symptoms." Voters Reveal Their Healthcare Priorities for the Next President in New eHealth Report The eHealth.com survey found that a majority of respondents, from both political parties, were open to the idea of repealing the Affordable Care Act (ACA) and instituting a single, government-run healthcare system for all Americans. National Kidney Foundation Reinforces Commitment to Latino Health During Hispanic Heritage Month Emphasizing the importance of early detection and prevention, the videos include a panel highlighting resources available to families affected by this disease, a chat with a nutrition expert about how everyday foods can help protect your kidneys, and a public service announcement urging Latinos to assess their risk at the foundation's website minuteforyourkidneys.org. Boston Scientific Closes Acquisition of Silk Road Medical, Inc. "The integration of the TCAR platform into our portfolio means we can offer a treatment option for patients suffering from carotid artery disease that can reduce the risk of stroke and lead to improved patient outcomes," said Cat Jennings, president, Vascular, Peripheral Interventions, Boston Scientific. Express Scripts Sues FTC, Demands Withdrawal of PBM Report The Cigna subsidiary demanded that the Federal Trade Commission (FTC) retract its July 2024 report, which examines the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs. Sanofi Shipping BEYFORTUS® in U.S. to Help Protect Babies Against RSV Disease; New Manufacturing Line Approved by FDA Ahead of RSV season, the company is planning for every eligible baby in the U.S. to have access to BEYFORTUS, the first and only long-acting monoclonal antibody approved for the prevention of RSV lower respiratory tract disease (LRTD) in newborns and infants born during or entering their first RSV season, and for children up to 24 months of age who remain vulnerable to severe RSV disease through their second RSV season. Zumba Partners with Spice Girl Mel B. to Launch Exclusive Class The global fitness brand and legendary Spice Girl deliver a brand-new class called "Spice Up Your Moves" — designed to be accessible to everyone and free on the Zumba App. "I feel like I smash it when I take a Zumba class, all of it in my own way!" said Mel B. U.S. Healthcare Spending More on AI, Cybersecurity, Other IT Investments-- Bain & Company and KLAS Research The firm's 2024 Healthcare IT Spending study finds 75% of providers and payers say they increased IT spending over the past year, a trend that is likely to continue. Organizations are also allocating greater spending to cybersecurity following the cyberattack on Change Healthcare—70% say they were directly affected. The Black Women's Health Imperative Releases Black Women Vote: 2024 Health Policy Voters Guide In celebration of National Voter Registration Day, the national non-profit developed a guide as a resource to help Black women better understand the policies and issues at stake that deeply impact their health. Aflac Makes New Resources Available to Support Children with Cancer and Blood Disorders To help spread awareness around Childhood Cancer and Sickle Cell Awareness Month, Aflac has a web page dedicated to helping those in the community and beyond. The Bridge to Brighter website offers digital toolkits, social media tiles and resources available in both English and Spanish. For more news like this, check out all of the latest health-related releases from PR Newswire. European Society for Medical Oncology (ESMO) Congress 2024 The influential oncology event in Barcelona last week featured the latest cancer data and findings, plus networking opportunities for clinicians, journalists and healthcare industry reps from all over the world. Here are a few of the late-breaking clinical trial announcements from ESMO disseminated over PR Newswire: AbbVie Showcases Advancement of Solid Tumor Pipeline at ESMO 2024, with New Data in Tumor Types with High Unmet Needs Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024 FDA Approves Novartis Kisqali® to Reduce Risk of Recurrence in People with HR+/HER2- Early Breast Cancer The Results of a Test Created in Barcelona for the Detection of Multiple Cancers Are Presented at ESMO SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024 Catch up on more ESMO news from PR Newswire. Do you have a health press release to distribute? Sign up with PR Newswire to share your story with the audiences who matter most. Helping Journalists Stay Up to Date on Industry News These are just a few of the recent press releases that consumers and the media should know about. To be notified of releases relevant to their coverage area, journalists can set up a custom newsfeed with PR Newswire for Journalists. Once they're signed up, reporters, bloggers, and freelancers have access to the following free features: Customization: Users can create customized newsfeeds that will deliver relevant news right to their inbox. Newsfeed results can be targeted by keywords, industry, subject, geography, and more. Photos and Videos: Thousands of multimedia assets are available to download and include in a journalist or blogger's next story. Subject Matter Experts: Journalists will have access to ProfNet, a database of industry experts to connect with as sources or for quotes in their articles. Related Resources: Our journalist- and blogger-focused blog, Beyond Bylines, features regular media news roundups, writing tips, upcoming events, and more. About PR Newswire PR Newswire is the industry's leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world. For questions, contact the team at [email protected]. SOURCE PR Newswire WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED